The arduous process of drug discovery and development

Drug development is a continuous process. Specifically, there will always be drugs in preclinical development and more advanced ones in clinical trials. These medicines are typically exorbitant in cost due to a variety of reasons, the most important of which is their small production volume coupled with the need to recoup the hefty investment needed … More The arduous process of drug discovery and development

Explaining checkpoint inhibitors in cancer immunotherapy

Checkpoint inhibitors are one class of potent drugs currently in clinical trials for use in cancer immunotherapy approaches for cancer treatment. But, their mode of operation and underlying concept is more difficult to understand compared to other classes of immunotherapy for cancer such as chimeric antigen receptor engineered T cells (CART).   Specifically, checkpoint inhibitors … More Explaining checkpoint inhibitors in cancer immunotherapy